SPS Members are Invited to attend the following Webinar, hosted by the American Society for Clinical Pharmacology and Therapeutics (ASCPT)
Presented by the ASCPT Early Development & Drug Safety Community
Title: Patient Reported Outcomes (PRO) Symptom Data to Complement Traditional Exposure-Response (ER) Analysis for Dose optimization During Breast Cancer Drug Development
Date and Time: Thursday, May 30, 2019, 1:00 pm ET
Speaker: Jeanne Fourie Zirkelbach, PhD
Moderator: Huiming Xia, PhD
Description: There is increasing interest in enhancing assessment of symptomatic adverse events (AEs) using patient self-reporting. In this presentation, exploratory efforts and results and future directions in term of how patient-reported outcome (PRO) - based Exposure Response analyses can complement conventional exposure-response (E-R) analysis will be discussed.
Learning Objective: Learn How Patient Report Outcome Endpoint Can Inform the Dose Selection and Dose Optimization.
Registration Required: https://attendee.gotowebinar.com/register/3232717416347253507
